Not that it makes much difference, but my calculation is that issued and outstanding shares are a little more than 6% of authorized shares (18,059,406 issued divided by 300,000,000 authorized).  Either way there is plenty of hurt possible, but could improve if we get the reduction of authorized shares that was promised pre-rs vote.

 

I also wanted to remind investors that Navidea had agreed to a 90-day lock-up period during which it would not sell additional securities.  That lock-up period expired this week. See   June 13, 2019 Prospectus though which NAVB sold 8,000,000 shares, including 4M to Scott @ .75pps.  That same agreement provided for "... warrants [to the Underwriter] to purchase up to 690,000 shares of common stock,...at an exercise price of $0.9375 per share ...exercisable... for five years...".  Furthermore,  the underwriter received a "...certain right of first refusal for a period of 12 months...".  but us shareholders are clueless as to the terms of that right of first refusal.